Filing Details
- Accession Number:
- 0001104659-21-001643
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-06 19:00:39
- Reporting Period:
- 2021-01-04
- Accepted Time:
- 2021-01-06 19:00:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1442836 | Mersana Therapeutics Inc. | MRSN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1782805 | Ashish Mandelia | C/O Mersana Therapeutics, Inc. 840 Memorial Drive Cambridge MA 02139 | Vp, Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-01-04 | 247 | $26.76 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Transaction effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2020.
- These shares were acquired under the Issuer's 2017 Employee Stock Purchase Plan on December 31, 2020.
Billionaire Hedge Funds
